We encourage you to read the Business Pulse article, which presents the achievements of Bioavlee in terms of the current development and sale of products, but also presents company further plans that wants to primarily conquer foreign markets with its solutions. “The Polish market is not yet well-off enough for companies to invest in innovative equipment. Money goes to more urgent needs, and the labor cost of native laboratory technicians is still much lower than in Western Europe, “comments Michał Wronecki, President of Bioavlee. We also recommend the commentary of Magdalena Surowiec – the Managing Partner of our Fund who, is working on a daily basis with biotechnology companies under the Leonarto Fund wings, and is meeting the challenges and problems of startups in this very demanding industry.

Talk – Action = Bullshit